Skin antiseptic products market to reach $9.8 billion by 2030 at 9.3% CAGR, driven by rising number of surgeries and increasing focus on infection prevention protocols.
Read More
Skeletal dysplasia drugs market to reach $4.31 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of bone disorders and rising need for targeted genetic therapies.
Read More
Single-use chromatography membrane market to reach $2.7 billion by 2030 at 15.4% CAGR, driven by increasing prevalence of personalized medicine and demand for flexible bioprocessing solutions.
Read More
Single-cell omics market to reach $5.27 billion by 2030 at 17.4% CAGR, driven by rising prevalence of cancer and increasing demand for advanced cellular-level disease analysis.
Read More
Silver ion wound spray market to reach $1.47 billion by 2030 at 11.4% CAGR, driven by increasing surgical procedures, rising road accidents, and growing prevalence of diabetes.
Read More
Silica mineral supplements market to reach $2.72 billion by 2030 at 9.5% CAGR, driven by increasing preference for natural and organic supplements and rising e-commerce penetration.
Read More
Sildenafil drug market to reach $5.44 billion by 2030 at 8.3% CAGR, driven by increasing prevalence of erectile dysfunction and lifestyle-related disorders.
Read More
Short-acting insulin market to reach $14.87 billion by 2030 at 5.2% CAGR, driven by increasing prevalence of type 1 diabetes worldwide.
Read More
Short-acting b2 agonists market to reach $5.39 billion by 2030 at 4.2% CAGR, driven by increasing prevalence of chronic obstructive pulmonary disease.
Read More
Shingles vaccine market to reach $10.96 billion by 2030 at 14.5% CAGR, driven by increasing number of vaccination programs for aging populations.
Read More